Founded in 2009 and based in New York City, the company is aiming to disrupt how women approach their lifelong fertility journey by empowering them and their physicians with more personalized information.

In August 2018, Celmatix announced a collaboration with pharma company Ferring to improve success rates of in vitro fertilization.